Concepedia

Author

Nancy Pryer

University of North Carolina at Chapel HillORCID

Also Known As

N K Pryer, N. K. Pryer, N.K. Pryer, Nancy K Pryer, Nancy K. Pryer, Nancy Pryer, Pryer, Nancy K.

72

Publications

9.2K

Citations

27

H-Index

85

Concepts

All Affiliations

University of North Carolina at Chapel HillNovartis (Switzerland)Novartis (United States)UCSF Helen Diller Family Comprehensive Cancer CenterNovartis Institutes for BioMedical Research
NP

About

Nancy Pryer is an author at University of North Carolina at Chapel Hill specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

18

6.5K

2

Natural Sciences

3

3

1.2K

3

Engineering

2

2

183

4

Health Sciences

2

2

2.1K

5

Social Sciences

2

2

193

Nancy Pryer

×

26

Publications

8.4K

Citations

25

H-Index

YearCitations

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Hui Gao, Joshua M. Korn, Stéphane Ferretti,

Nature Medicine

2015

1.4K

Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts

David W. Fry, Patricia J. Harvey, Paul R. Keller,

Molecular Cancer Therapeutics

2004

1.2K

Dynamic instability of individual microtubules analyzed by video light microscopy: rate constants and transition frequencies.

R. A. Walker, E. Timothy O’Brien, Nancy Pryer,

The Journal of Cell Biology

1988

994

Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells

Brian Ruffell, Debbie Chang-Strachan, Vivien W. Chan,

Cancer Cell

2014

967

Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance

Meghna Das Thakur, Fernando Salangsang, Allison Landman,

Nature

2013

734

SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer.

Tinya J. Abrams, Leslie B. Lee, Lesley Murray,

PubMed

2003

639

CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8<sup>+</sup>T cells

Debbie Strachan, Brian Ruffell, Yoko Oei,

OncoImmunology

2013

371

Real-time observations of microtubule dynamic instability in living cells.

Lynne Cassimeris, Nancy Pryer, Edward D. Salmon

The Journal of Cell Biology

1988

367

SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model

Lesley Murray, Tinya J. Abrams, Kelly R. Long,

Clinical & Experimental Metastasis

2003

304

Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer.

Tinya J. Abrams, Lesley Murray, Enrico Pesenti,

PubMed

2003

252

Page 1